A Study of Bioavailability and Food Effect of SACT-1 and Edurant® Tablets in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 9, 2021

Primary Completion Date

November 20, 2021

Study Completion Date

December 14, 2021

Conditions

Healthy Subject

Interventions

DRUG

SACT-1

Single administartion of 150mg SACT-1

DRUG

EDURANT 25Mg Tablet

Single administartion of six EDURANT 25mg tablets (Total 150mg)

Trial Locations (1)

Novum Pharmaceutical Research Services, Fargo

All Listed Sponsors

lead

Aptorum International Limited

INDUSTRY

NCT05358756 - A Study of Bioavailability and Food Effect of SACT-1 and Edurant® Tablets in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter